Showing results (551-560 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|August 7, 2014
Tolerability and safety of the new anti-obesity medicationsVojtech Hainer, Irena Aldhoon-HainerováDrug Safety|August 7, 2013
Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infectionEvans Sagwa, Nunurai Ruswa, Jean Paul Musasa, et al.Drug Safety|December 31, 2015
Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative StudiesMichael W Dunne, George H Talbot, Helen W Boucher, et al.Drug Safety|December 31, 2015
A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting DatabasesMickael Arnaud, Francesco Salvo, Ismaïl Ahmed, et al.Drug Safety|January 11, 2016
Comparative Safety and Tolerability of Prostacyclins in Pulmonary HypertensionCaroline O'Connell, David Amar, Athénaïs Boucly, et al.Drug Safety|January 13, 2016
Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®Haggar H Ampadu, Jarno Hoekman, Marieke L de Bruin, et al.Drug Safety|December 23, 2015
Appropriate Polypharmacy and Medicine Safety: When Many is not Too ManyCathal A Cadogan, Cristín Ryan, Carmel M HughesDrug Safety|October 9, 2015
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO ProjectEmanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, et al.Drug Safety|January 23, 2016
Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and PatientsSheriza N Baksh, Walid F Gellad, G Caleb AlexanderPageof 308